About this trial
The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a strict and permissive threshold. The strict threshold is defined as two abnormal values or more over a one-week period (two fasting values elevated, two of the same post prandial values elevated, or 1 fasting and 1 post prandial value elevated), whereas the permissive threshold is defined as 50% of values elevated over 1 week (50% of overall fasting values, 50% of postprandial values, or 50% of overall values).
Eligibility criteria
Qualifiers
Live, non-anomalous fetus
Literacy in English, Spanish, Mandarin, or Arabic
Patients are also required to provide consent, demonstrate an understanding of the purpose of the study, and agree to the study protocol.
Disqualifiers
<18 years at EDD
pre-existing diabetes or diagnosis of GDM before 24 weeks
multi-fetal gestation
known major fetal anomaly
Trial design
Treatments tested in this trial
- Insulin
Treatment groups
Sponsors and collaborators
Thomas Jefferson University
Lead sponsor
University of Rochester
Collaborator